
çèã«ã¯ã¯ãã³ïŒã³ã¹ãã³ã®ãµãã©ã€ã€ãŒãããªã¹ã»ã©ã³ããåç©ã¯ã¯ãã³æ¥çš®ã®æ £è¡ããããæ¶è²»è ã®åçºãè²·ã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ã³ã¹ãã³ã®çèãµãã©ã€ã€ãŒã§ããããªã¹ã»ã©ã³ãã¯ãèªç€Ÿã®çã«ã¯ã¯ãã³ãæ¥çš®ããŠããããšãèªããæ¶è²»è ã®éã§é£åã®å®å šæ§ãšéææ§ã«é¢ããæžå¿µãé«ããŠããã
ãã ã»ã¬ã³ãã®ãããªæ¹è©å®¶ã¯ãããªã¹ã»ã©ã³ããåŸæ¥ã®ã¯ã¯ãã³ã䜿çšããŠããã«ãããããããã¯ã¯ãã³ãç¹ã«mRNAããŒã¹ã®ã¯ã¯ãã³ãé£åã«äœ¿çšããããšã¯èª€è§£ãæããæå®³ã§ãããšäž»åŒµããŠããã
ããªã¹ã»ã©ã³ãã¯ãåç©çŠç¥ã®å°éå®¶ã§ãããã³ãã«ã»ã°ã©ã³ãã£ã³å士ãšååããåç©çŠç¥ãšçŸç äºé²ãžã®ã³ãããã¡ã³ãã®äžç°ãšããŠããã®ã¯ã¯ãã³æ¥çš®ãããã³ã«ãæè·ããŠããã
ãã®èšäºã§ã¯ãçã«äœ¿çšãããåŸæ¥ã®ã¯ã¯ãã³ãšmRNAã¯ã¯ãã³ã®éããæç¢ºã«ããmRNAã¯ã¯ãã³ã¯çŸåšãç±³åœã§ã¯èçãžã®äœ¿çšãæ¿èªãããŠããªãããšã匷調ããŠããã
ãã®è«äºã¯ãæ¶è²»è ãé£åã®éžæã«ã€ããŠæç¢ºãªè¡šç€ºãšæ å ±ãæ±ããäžãé£åæ¥çã«ãããä¿¡é Œãšéææ§ã®éèŠæ§ãé«ãŸã£ãŠããããšãæµ®ã圫ãã«ããŠããã
æ¶è²»è ã®é£åãžã®èŠæå¿ãé«ãŸãäžãã³ã¹ãã³ã®çèãµãã©ã€ã€ãŒã§ããããªã¹ã»ã©ã³ãã¯ãçã«ã¯ã¯ãã³ãæ¥çš®ããŠããããšãå ¬ç¶ãšèªããç©è°ãéžããŠãããå瀟ã¯åç©çŠç¥ãšæç¶å¯èœãªæ £è¡ãžã®ã³ãããã¡ã³ãã売ãç©ã«ããŠãããããã®äºå®ãæããã«ãªã£ãããšã§ãäžéšã®æ¶è²»è ã¯èªåãã¡ã®é£åäŸçµŠã®å®å šæ§ãšéææ§ã«çåãæ±ãããã«ãªã£ããå€ãã®æ¶è²»è ã«ãšã£ãŠãçèã«ã¯ã¯ãã³ãæ··å ¥ããŠããããšã¯äžå®ã§ããã°ããã§ãªããååŒãæå¿µããããåŸãªãããšãªã®ã ã
ååïŒé£åã«ã¯ã¯ãã³ïŒ
å®¶çã®ã¯ã¯ãã³ã«é¢ããè°è«ã¯ä»ã«å§ãŸã£ãããšã§ã¯ãªãããCOVID-19ã®ãã³ãããã¯ãšmRNAã¯ã¯ãã³æè¡ã®å°é ãåããŠãæ°ããªç·æ¥æ§ã垯ã³ãŠãããããã¥ã©ã«ã»ãã«ã¹ãšæ¶è²»è
ã®éææ§ã®èåãªæå±è
ã§ãããã ã»ã¬ã³ãã®ãããªæ¹è©å®¶ã¯ããã®æ
£è¡ã«åŒ·ãå察ã®å£°ãäžããŠããããããã¯ç§ã«ãšã£ãŠå€§ããªåé¡ã ãç§ã®å®¶æã¯ã³ã¹ãã³ãããå©çšããŸããã圌ãã ããªãŒã¬ãã㯠ãçèã« ãã¯ã¯ãã³ ããæ··å
¥ããŠãããšããäºå®ã¯ã誀解ãæãããæãããããšã§ããã
ã¬ã³ãã®æžå¿µã¯ãé£åã«å«ãŸããã¯ã¯ãã³ãç¹ã«mRNAæè¡ãé¢äžããã¯ã¯ãã³ã«å¯ŸããŠèŠæå¿ãæã€æ¶è²»è ã®å¢å ã«åŒå¿ããŠãããããªã¹ã»ã©ã³ãã¯ãmRNAããŒã¹ã®ã¯ã¯ãã³ã§ã¯ãªããåŸæ¥ã®ã¯ã¯ãã³ã䜿çšããŠããããšãæããã«ããŠãããããã®åºå¥ã¯ã»ãšãã©äžå®ãåããããã®ã«ã¯ãªã£ãŠããªããå€ãã®äººã«ãšã£ãŠãé£åã«ã¯ã¯ãã³ãå«ãŸããŠãããšããã ãã§ãèµ€æãæ²ããã«ã¯ååãªã®ã§ããã
ããªã¹ç§å Žã®åŒæ åç©çŠç¥ãšé£ã®å®å š
ã«ãªãã©ã«ãã¢ãæ ç¹ãšããçèçç£è
ããªã¹ã»ã©ã³ãã¯ãåç©çŠç¥ãšæç¶å¯èœãªèŸ²æ³ãžã®ã³ãããã¡ã³ããé·å¹ŽèªããšããŠããã2019幎ã®å£°æã§å瀟ã¯ã人éçãªæ±ããç
æ°ã®äºé²ãé«å質ã®çèçç£ãéèŠããçã®é£Œè²æ¹æ³ã«ã€ããŠæŠèª¬ããããããªã¹ã»ã©ã³ãã¯ãçã®é£Œè²å Žæãé£Œè²æ¹æ³ããã絊é€ãå å·¥ãæµéã«è³ããŸã§ãçç£ã®ããããåŽé¢ã管çããŠããããã人éçãªåãæ±ãã培åºããŠããŸãããšå£°æã«ã¯èšãããŠããã
å瀟ã®ã¯ã¯ãã³æ¥çš®ãããã³ã«ã¯ãç æ°ãæå°éã«æããæçç©è³ªã®å¿ èŠæ§ãæžããããã®åºç¯ãªæŠç¥ã®äžç°ã§ãããã»ãšãã©ã®èççç£è ã¯ãå°ãªããšãããã€ãã®ã¯ã¯ãã³ã䜿çšããŠããããäžè¬çãªçã®çŸç ãäºé²ããããã®ã¯ã¯ãã³æ¥çš®ã匷åãªå ç«ã·ã¹ãã ããµããŒãããããã®ããã©ã«ã®è£çµŠããããŠã¹ãã¬ã¹ã®å°ãªãçã®åãæ±ãã¯ããã®ç®æšãéæããã®ã«åœ¹ç«ã¡ãŸãããšå£°æã¯èª¬æããŠãããããªã¹ã»ã©ã³ãã¯ãŸããåç©çŠç¥ã®å°éå®¶ãšããŠæåãªãã³ãã«ã»ã°ã©ã³ãã£ã³å士ãšååããçã®å¥åº·ãæåªå ããæœèšãæ £è¡ãèšèšããŠããã
ããããä¿èšŒã«ãããããããããªã¹ã»ã©ã³ããçã«ã¯ã¯ãã³ãæ¥çš®ããŠããããšãæããã«ãªããäžéšã®æ¶è²»è ã¯è£åããããšæããŠããããªãŒã¬ããã¯ãèªç¶é£åãåªå ãã人ã ã«ãšã£ãŠãçèã«ã¯ã¯ãã³ã䜿ãããŠãããšããèãã¯ã圌ãã®äŸ¡å€èгãšã¯çžåãããã®ã ãããªãŒã¬ããã¯ãè²·ãã»ã©æ°ã䜿ã£ãŠããã®ãªããäœåã«ãéãæã£ãŠè²·ã£ãŠããé£ã¹ç©ã«éºäŒåæ²»çã®æ¯ãæ··ãã£ãŠãããã©ããç¥ããããªãã®ã§ããïŒ" ãšã¬ã³ãã¯ãã€ãŒãã§åããããããšã¬ã³ãã¯ãã€ãŒãã§åããããã
å®¶çã¯ã¯ãã³ã®ç§åŠ
è«äºãçè§£ããããã«ã¯ãåŸæ¥ã®ã¯ã¯ãã³ãšmRNAã¯ã¯ãã³ãåºå¥ããããšãéèŠã§ãããåææã§ãšã¯ã¹ãã³ã·ã§ã³å®¶çç£å»åž«ã§ããã«ãŒã»ã¹ããªãã¯ã©ã³ãå士ã«ãããšãåŸæ¥ã®ççšã¯ã¯ãã³ã¯2ã€ã®ã«ããŽãªãŒã«åé¡ããããMLVã¯ã¯ãã³ã«ã¯åŒ±æ¯åããçãŠã€ã«ã¹ãå«ãŸããŠãããäžæ¹ã殺åŠåã¯ã¯ãã³ã«ã¯äžæŽ»åãŠã€ã«ã¹ãå«ãŸããŠããŸããã©ã¡ããç
æ°ãåŒãèµ·ããããšãªãå
ç«åå¿ãåºæ¿ããããã«èšèšãããŠããã
äžæ¹ãmRNAã¯ã¯ãã³ã¯æ°ããæè¡ã§ãéºäŒç©è³ªãçšããŠçްèã«å ç«åå¿ãåŒãèµ·ããã¿ã³ãã¯è³ªã®ç£çãæç€ºãããmRNAã¯ã¯ãã³ã¯COVID-19ã®ãã³ãããã¯ã®éãããã«åºã䜿çšãããããçŸåšãçãžã®äœ¿çšã¯æ¿èªãããŠããªãããçŸåšãç±³åœã§èçãžã®äœ¿çšãèªå¯ãããŠããmRNAã¯ã¯ãã³ã¯ãããŸããããçç£èŸ²å®¶ãç§å Žäž»ã¯ãå€ãã®ç æ°ã®æ²»çãäºé²ã®ããã«çã«ã¯ã¯ãã³ãæ¥çš®ããŠããŸãããçŸåšã®ãšããããããã®ã¯ã¯ãã³ã®ã©ãã«ãmRNAæè¡ã¯å«ãŸããŠããŸããããåœæã¯ããã ã£ããããããªããããã®åŸãç§åŠè ãã¡ã¯mRNAã¯ã¯ãã³ã®éçºã«åãçµãã§ããã
æŽå²çèæ¯ ã¯ã¯ãã³ãšé£åå®å š
å®¶çã«ãããã¯ã¯ãã³ã®äœ¿çšã¯ãå£è¹ç«ããã«ã»ã©ç
ãšãã£ãç
æ°ãåç©ãšäººéã®å¥åº·ãè
ãããŠãã20äžçŽåé ã«ããã®ãŒãã以æ¥ãã¯ã¯ãã³ã¯çŸä»£èŸ²æ¥ã®èŠãšãªããäŒæç
ã®çºçãäºé²ããå®å®ããé£ç³§äŸçµŠã確ä¿ããã®ã«åœ¹ç«ã£ãŠããããããããªãŒã¬ããã¯ãèªç¶é£åéåã®å°é ã«ãããããããæ
£è¡ã«å¯Ÿããç£èŠã®ç®ãå³ãããªã£ãŠããã
äžéšã®æ¶è²»è ã«ãšã£ãŠããã®åé¡ã¯å®å šæ§ã ãã§ãªããéææ§ã®åé¡ã§ããããã³ã¹ãã³ã¯ãéºäŒåæ²»çã®æ¯ã«ããããã ããªãŒã¬ãã㯠ãé£åã«ã©ãã«ãä»ããæ¶è²»è ããããé£ã¹ããã©ããã倿ã§ããããã«ããã®ã ãããïŒãšã¬ã³ãã¯å°ãããããªã¹ã»ã©ã³ãã¯mRNAã¯ã¯ãã³ã䜿çšããŠããªãããšãæããã«ããŠããããæç¢ºãªè¡šç€ºããªããããå€ãã®æ¶è²»è ã¯äžå®ãæããŠããã
åéæŽã ïŒ ä¿¡é Œãšéææ§
é£åäžã®ã¯ã¯ãã³ããããè°è«ãç¶ãäžãã²ãšã€ã¯ã£ããããŠããããšã¯ãä¿¡é Œãšéææ§ããããŸã§ä»¥äžã«éèŠã ãšããããšã ãããªã¹ã»ã©ã³ãã®ãããªäŒæ¥ãã³ã¹ãã³ã®ãããªå°å£²æ¥è
ã«ãšã£ãŠã®èª²é¡ã¯ãçŸç
äºé²ã®å¿
èŠæ§ãšèªç¶é£åããªãŒã¬ããã¯é£åãžã®éèŠã®é«ãŸããšã®ãã©ã³ã¹ããšãããšã§ãããæ¶è²»è
ã«ãšã£ãŠã¯ããŸããŸãè€éåããé£ã®ã·ã¹ãã ããèªä¿¡ãšææ°ãããã£ãŠããã²ãŒãããããšã課é¡ãšãªãã ããã
ãã®äžæ¹ã§ããã®è«äºã¯ãç§ãã¡ãé£ã«é¢ããŠè¡ãéžæãæ·±ãå人çãªãã®ã§ããããšããããŠç§ãã¡ã®é£åã«äžŠã¶ãã®ã«ã€ããŠã®è©±ãåãã¯ãŸã çµãã£ãŠããªãããšãæãèµ·ãããããã®ã§ãããããªããèªç¶ãªå¥åº·ãåŒ·ãæ¯æãã人ã§ãããè¿ä»£çãªèŸ²æ¥ãæ¯æãã人ã§ãããã²ãšã€ç¢ºããªããšã¯ãé£åäžã®ã¯ã¯ãã³ããããè«äºã¯ä»åŸãç¶ããšããããšã ã